Scope review of research status and implications of financial toxicity in patients with heart failure
10.3760/cma.j.cn211501-20240416-00922
- VernacularTitle:心力衰竭患者经济毒性研究现状及启示的范围综述
- Author:
Kexin WANG
1
;
Xinyu HE
;
Yaping HE
;
Ruilian LI
;
Guoyan ZHANG
;
Taofang JIAO
;
Li LI
Author Information
1. 西南医科大学护理学院，泸州 646099
- Keywords:
Heart failure;
Financial toxicity;
Research status;
Influencing factors;
Scope review
- From:
Chinese Journal of Practical Nursing
2024;40(31):2474-2481
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To understand the current status of financial toxicity in patients with heart failure and the factors affecting it, and to provide ideas for making personalized and informed decisions.Methods:Using a scoping review methodological framework, PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, VIP, Wanfang, and SinoMed Databases were searched and screened for relevant literature on financial toxicity in patients with heart failure, with a timeframe of January 1, 2014-October 31, 2023, respectively. Relevant literature was identified based on inclusion and exclusion criteria, and data were extracted, collected, summarized, and the findings were reported.Results:Ten literatures that met the inclusion and exclusion criteria were identified. The results showed 5 cross-sectional surveys, 2 qualitative studies, and 1 each of reviews, mixed studies and commentaries. Heart failure patients generally faced high levels of financial toxicity, the incidence and severity of patient financial toxicity varied somewhat between study outcomes. Factors influencing financial toxicity in heart failure patients included age, education level, family income level, discussion of medical costs with physicians, type of insurance the patient had, and occupational status.Conclusions:In the future, we can develop and apply a specialized assessment tool for financial toxicity in heart failure patients in China, further explore the factors affecting financial toxicity in heart failure patients, and formulate personalized treatment plans and financial support strategies for patients according to the influencing factors, so as to reduce the impact of financial toxicity on heart failure patients.
